Cited by 860Psoriasis: Treatment and PathogenesisRheumatoid Arthritis Research and TherapiesOcular Diseases and Behçet’s Syndrome

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

Hueber, Wolfgang, Patel, Dhavalkumar D., Dryja, Thaddeus, Wright, Andrew M., Koroleva, Irina, Bruin, Gerard, Antoni, Christian, Draelos, Zoe +17 more·2010·Science Translational Medicine

Abstract

A human antibody to interleukin-17A is well tolerated and may be effective in the treatment of psoriasis, rheumatoid arthritis, and noninfectious uveitis.

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.3001107

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IL-17A/F double-deficient mice are highly resistant to EAE development.

    “when using genetically deficient IL-17A and IL-17F mice, our own unpublished studies and those of others have shown that IL-17A/F double-deficient mice were highly resistant to the development of EAE”

    From TH17 cell heterogeneity and its role in tissue inflammation (2023) · cites this paper as [116]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hueber, W., Patel, D. D., Dryja, T., Wright, A. M., Koroleva, I., Bruin, G., Antoni, C., Draelos, Z., Gold, M. H., the Psoriasis Study Group, Durez, P., Tak, P. P., Gomez-Reino, J. J., the Rheumatoid Arthritis Study Group, Foster, C. S., Kim, R. Y., Samson, C. M., Falk, N. S., Chu, D. S., Callanan, D., Nguyen, Q. D., the Uveitis Study Group, Rose, K., Haider, A., & Di Padova, F.
Affiliations
  • Novartis Institutes for BioMedical Research (CH)
  • Novartis (Switzerland) (CH)
  • Novartis (United States) (US)
  • Dermatology Consulting Services (US)
  • Tennessee Clinical Research Center (US)
  • UCLouvain (BE)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Universidade de Santiago de Compostela (ES)
  • Hospital Clínico Universitario/Universidad de Santiago de Compostela, 15706 Santiago de Compostela, Spain.
  • Retina Consultants of Texas (US)
  • New York Eye and Ear Infirmary (US)
  • Texas Retina Associates (United States) (US)
  • Johns Hopkins University (US)
  • Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland.
Corresponding author
Patel, Dhavalkumar D.
Venue
Science Translational Medicine
Published
2010-10-06
Volume
2
Issue
52
Pages
52ra72-52ra72
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W2112128505
Cited by
860
References
48
Citations by year
2026: 5 · 2025: 14 · 2024: 24 · 2023: 24 · 2022: 30 · 2021: 36 · 2020: 36 · 2019: 48 · 2018: 42 · 2017: 75 · 2016: 71 · 2015: 78 · 2014: 96 · 2013: 106 · 2012: 107
FWCI
38.05
Type
journal article
Language
en
Open access
closed
Locations
  • Science Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • DIAL (Catholic University of Leuven) (submittedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords
IL-17A, neutralizing antibodies, psoriasis, rheumatoid arthritis, non-infectious uveitis, Th17 cells, autoimmunity, inflammatory diseases, PASI, ACR20 response, adverse events, infection
MeSH terms
Adolescent, Adult, Aged, Animals, Antibodies, Antibodies, Monoclonal, Arthritis, Rheumatoid, Double-Blind Method, Humans, Middle Aged, Placebos, Psoriasis, Uveitis, Treatment Outcome, Interleukin-17, Young Adult, Antibodies, Monoclonal, Humanized

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review